Allergan patent suit loss sends stock down 5% By: MarketWatch October 16, 2017 at 14:33 PM EDT Allergan had made a widely-criticized agreement with an American Indian tribe to defend a key product. This lawsuit could render it all moot. Read More >> Related Stocks: Allergan Plc Standard & Poors 500